Quotient Limited SA

Business Name: Quotient Limited SA
Business Genre:
Business Description:

A tranfusion diagnostics company and proprietor of MosaiQ, which is a fully automated blood grouping and disease serology testing platform [1,2]

City: Newtown
State: PA
Country: USA
Additional Addresses: Eysins, Switzerland
Data/Evidence of Effectiveness: “100% sensitivity and 99.8% specificity claim, the test has the best in class performance and overall agreement published to date” [7]
Complimentary Products Needed to Perform Test: MosaiQ machine [7]
Setting of Care: Not specified
Current Status / Clinical Development Stage / Expected Milestones: The test does not have EUA but it is CE marked and can be purchased in Europe and Switzerland [7]
Funding & Ownership : Private/Investors [3-4]
Business Model: The company is the proprietor of MosaiQ, which is widely used for blood grouping and serology testing in clinical settings [1,3]. This company has a total funding amount of 43.2M [4].
IP: Proprietary Q-Plex MosaiQ platform [1]
History & Origins : The company has been in the tranfusion diagnostics market for over 30 years [3]. It was founded by Paul Cowan in 2008 [4]
Date EUA Issued: N/A
Sources: [1]; [2]; [3]; [4] [5]; [6]
Organization: Franz Walt (CEO); Peter Buhler (CFO); Jeremy Stackawitz (CCO); Edward Farrell (COO) [5]
Time to Result: 35 minutes to initial results, 24 seconds to subsequent ones [7]
Test Sample Type: blood[7]
Technology Overview: High throughput microarray assay that can be run in the MosaiQ instrument to detect IgM and IgG antibodies to SARS-CoV-2 [7]
Testing Type: detects IgG and IgM antibodies [7]
Test Category: SEROLOGY
Test Name: MosaiQ COVID-19 Antibody Microarray
Clinical Application & Need: recent/prior infection/immunity [7]

Send Message to listing owner